SVLSF VI, LLC purchased $1.3M of TRXB (indirect holdings)
SVLSF VI, LLC purchased 92,857 indirectly-held shares of TRex Bio, Inc. (TRXB) at $14.00 ($1.30M total) across 2 trades on 2026-10-08. Filed jointly with SV Life Sciences Fund VI (GP), L.P. (10% owner) and SV Life Sciences Fund VI, L.P. (10% owner).
How this was made
The 30-second read
Why it matters
The insider buy adds a modest amount of shares to an existing large stake, signaling confidence but unlikely to cause a sharp price swing.
Market read
Primary insider purchase filing; modest size limits market impact but provides a positive signal for traders.
What to watch
The transaction size is modest relative to market cap; any price move may be muted.
Background
SEC Form 4 filing by SVLSF VI, LLC, a 10% owner of TRex Bio, reporting an open‑market purchase of 92,857 shares at $14 each.
Ticker impact
Form 4 shows a 10% owner buying 92,857 shares at $14 each, increasing holdings to 7,356 shares.
likely modest upward pressure as the market prices in the insider buy
The buyer is a 10% owner, the purchase is sizable for a micro‑cap but still under $2 M, indicating a positive signal without immediate large price move.
Market effects
Minimal; the trade is company‑specific and does not affect the broader biotech sector.
None
None
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a strong endorsement.
Key entities
- companyTRex Bio, Inc.
Biotech firm whose stock ticker is TRXB.
- insiderSVLSF VI, LLC
10% owner filing the purchase.